Fushine Pharmaceuticals Chairman Bao Jianhua and his delegation recently attended the "Jiangxi Normal University 2024 Scientific Research Innovation Conference" and signed a project achievement transformation cooperation agreement with Jiangxi Normal University. Under the agreement, both the university and the company will leverage their respective resources to advance the intelligent, fully continuous flow process from the laboratory to industrialization, achieving intelligent and efficient production, further reducing production costs, and improving production safety.

The conference was hosted by Jiangxi Normal University with the theme of "Promoting scientific research innovation, assisting the high-quality development of the school, and achieving breakthroughs in 'Double First-Class'." Participants included Song Dexiong, Secretary of the Party Leadership Group and Director of the Department of Science and Technology of Jiangxi Province, Sun Zhaohai, member of the Education Working Committee of the Jiangxi Provincial Party Committee, Major General Li Ming, Director of the National Defense Education Office of the Chinese Society of Aeronautics and Astronautics, school leaders Huang Jiawen, Chen Fener, Wang Yang, Xiang Guoxiong, Shu Pinggui, Liu Limin, Dong Shenghong, and Zhong Yexi, Cao Zehua, member of the Standing Committee of the Party Committee of the University, and representatives of entrepreneurs from China Resources Double-Crane Pharmaceutical Co., Ltd., Jiangxi Fushine Pharmaceutical Co., Ltd., and other companies, totaling more than 300 people, attended the conference.



Technological innovation leads industrial development

Academician Chen Fener said in her speech, "General Secretary Xi Jinping once pointed out that scientific and technological innovation is like a lever that moves the earth, always creating unexpected miracles. In 2024, the university will accelerate the research and development of key core technologies, focus on solving bottleneck technical problems, and more proactively serve Jiangxi's development of new quality productivity. In particular, the research and development and achievement transformation of key continuous flow manufacturing technologies have been highly recognized by the Provincial Party Committee and Government, the Provincial Department of Science and Technology, the Provincial Department of Education, and related enterprises. This high-tech and cutting-edge technology is safe, green, efficient, economical, convenient, and intelligent. It will trigger disruptive and revolutionary epoch-making changes in manufacturing industries such as petrochemicals and oil refining. The university will also sign strategic cooperation agreements and project achievement transformation agreements on intelligent fully continuous flow with companies such as China Resources Double-Crane Pharmaceutical Co., Ltd. and Jiangxi Fushine Pharmaceutical Co., Ltd."

Director Song Dexiong mentioned in his speech: "The Provincial Department of Science and Technology is striving to build a 1+N+1 result transformation service system. Local universities should serve local economic development. They should focus on economic development needs, actively integrate into the overall economic and social development of the province, timely adjust the main direction of scientific and technological innovation, strengthen property rights coordination, continuously explore new tracks, promote the transformation of scientific and technological achievements, write papers on the land of the motherland, and realize that projects come from the front line of industry, platforms are built on the front line of industry, results are transformed on the front line of industry, and talents grow on the front line of industry!"



Fushine Pharmaceuticals' New Exploration of Intelligent Fully Continuous Flow

At the end of the meeting, Li Huiyue, Vice Chairman of Fushine Pharmaceuticals, and Xiang Guoxiong, Vice President of Jiangxi Normal University, signed a cooperation agreement on the transformation of project results.This project achievement transformation collaboration with Jiangxi Normal University is another important step for Fushine Pharmaceuticals to implement university-enterprise collaboration, as well as a new venture into intelligent, fully continuous production. This initiative will facilitate the intelligent and continuous production of the company's products, enhance inherent safety, reduce production costs, improve the market competitiveness of the company's products, and drive high-quality development. We are confident that as Fushine Pharmaceuticals continues to innovate and inject new scientific and technological momentum into its development, it will write an even more glorious chapter for human health.